Іздеу

The place of glyflozins in the management of type 2 diabetes mellitus

Sharonova L., Verbovoy A.

(Rus)

№ 11 (2018)

Features of glycemic control in patients with type 2 diabetes mellitus and chronic heart failure

Demidova T., Titova V.

(Rus)

№ 2 (2018)

Efficiency of different schemes of antihelicbacter therapy in patients with chronic gastroduodenal diseases and type 2 diabetes mellitus

Fedorchenko Y., Martynyuk M.

(Rus)

№ 16 (2017)

Fixed-dose combinations in the therapy of type 2 diabetes mellitus: the way to achieving good glycemic control

Biryukova E.

(Rus)

№ 16 (2016)

Modern approaches to the treatment of patients with type 2 diabetes mellitus

Antsiferov M., Fadeev V., Morgunova T.

(Rus)

№ 16 (2014)

Leptin i gormonal'no-metabolicheskie pokazateli u bol'nykh bronkhial'noy astmoy i pri ee sochetanii s sakharnym diabetom 2 tipa

Verbovoy A., Sharonova L., Akhmerova R.

(Rus)

№ 5 (2014)

VLIYaNIE KOMBINATsII METFORMINA I VILDAGLIPTINA NA POKAZATELI UGLEVODNOGO I ZhIROVOGO OBMENOV U BOL'NYKh SAKhARNYM DIABETOM 2 TIPA

Abaeva M., Nazhmutdinova P., Ametov A.

(Rus)

№ 16 (2013)

Bazal'naya insulinoterapiya: opyt klinicheskoy praktiki

Chernikova N., Ametov A., Antsiferov M.

(Rus)

№ 5 (2013)

KLINIChESKIE PREIMUShchESTVA PERVOGO ANALOGA ChELOVEChESKOGO GPP-1 LIRAGLUTIDA PRI LEChENII BOL'NYKh SAKhARNYM DIABETOM 2 TIPA

Demidova I.

(Rus)

№ 5 (2013)

SOSTOYaNIE KOSTNOY TKANI PRI SAKhARNOM DIABETE 2 TIPA

Ruyatkina L., Lomova A., Ruyatkin D.

(Rus)

№ 7 (2012)

DIPEPTIDYL PEPTIDASE-4 INHIBITORS IN COMBINATION WITH METFORMIN: EXPERIENCE OF USE OF GALVUS MET IN REAL-LIFE CLINICAL PRACTICE IN MOSCOW

Antsiferov M., Antsiferov M.

№ 3 (2012)

APPLICATION OF VILDAGLIPTIN IN COMBINATION WITH INSULIN IN TYPE 2 DIABETES MELLITUS

Antsiferov M., Antsiferov M.

№ 16 (2011)

Galvus and Galvus Met in treatment of elderly patients with type 2 diabetes mellitu

Antsiferov M., Antciferov M.

№ 5 (2011)

CLINICAL AND METABOLIC EFFICIENCY OF DRUG DIBIKOR IN PATIENTS WITH TYPE 2 DIABETES MELLITUS

Severina T., Popkova E., Trel'skaya N., Emel'yanov V., Severina T., Popkova Y., Trelskaya N., Yemelyanov V.

№ 3 (2011)

INITIATION OF THERAPY WITH INSULIN PUMP IN PATIENTS WITH TYPE 1 DIABETES

Antsiferov M., Koteshkova O., Kleymenova S., Antsiferov M., Koteshkova O., Kleimenko S.

№ 16 (2010)

WHEN TO BEGIN COMBINED THERAPY OF TYPE 2 DIABETES MELLITUS

Petunina N., Petunina N.

№ 3 (2010)

Advance - movement forward

Petunina N., Petunina N.

№ 17 (2009)

OPTIMIZATsIYa INSULINOTERAPII SAKhARNOGO DIABETA TIPA 1 V PERIOD BEREMENNOSTI

Demidova I., Mel'nikova E., Arbatskaya N., Ignatova N.

№ 15 (2009)

Insulin resistance and heart diseases: is there a relationship?

Drapkina O., Smirin V., Ivashkin V., Drapkina O., Smirin V., Ivaschkin V.

№ 3 (2009)

Possibilities of insulin glargine (Lantus ®) use for treatment of type 2 diabetes mellitus in the outpatient endocrinology services: an analysis of the register LAUREL

Antsiferov M., Petraneva E., Anciferov M., Petraneva E.

Том 32, № 2 (2025)

Efficiency of a fixed combination of insulin glargine and lixisenatide in everyday clinical practice

Elsukova O., Nikitina E.

(Rus)

Том 31, № 2 (2024)

Clinical case of achieving compensation for type 2 diabetes mellitus in preparation for pregnancy in a woman of reproductive age

Markina J.

(Rus)

Том 31, № 2 (2024)

Vildagliptin – 15 years in active service with diabetologists

Pavlova M.

(Rus)

Theory and practice of use of dipeptidyl peptidase-4 inhibitors: focus on evogliptin

Biryukova E.

(Rus)

Том 29, № 11/12 (2022)

Cardiovascular outcomes during treatment with dipeptidyl peptidase-4 inhibitors depending on renal function and combination with metformin: a systematic review

Petunina N., Martirosyan N., Valeeva F.

(Rus)

Том 28, № 12 (2021)

Differentiated approach to metformin therapy in newly diagnosed type 2 diabetes mellitus from the perspective of pharmacogenetics

Shorokhova P., Baranov V.

(Rus)

Improvement of the efficacy of conservative treatment of rhinosinusitis and otitis media in patients with type 2 diabetes mellitus: an open-label prospective randomized clinical trial

Shkurova N., Baranova N., Fedin A.

(Rus)

Potential drug interactions of oral hypoglycemic drugs that increase the risk of hypoglycemia

Pereverzev A., Ostroumova O., Tkacheva O.

(Rus)

№ 11 (2018)

Apelin: biological and pathophysiological effects

Dolgikh Y., Verbovoy A.

(Rus)

№ 5 (2017)

PATHOPHYSIOLOGICAL APPROACH AS A BASIS FOR THE SELECTION OF STRATEGY FOR THE SUCCESS TREATMENT OF TYPE 2 DIABETES MELLITUS

Ametov A.

(Rus)

№ 5 (2016)

EMPAGLIFLOZIN: ENHANCEMENT OF POTENTIALS OF THE TREATMENT OF TYPE 2 DIABETES MELLITUS

Biryukova E.

(Rus)

№ 17 (2015)

Rezul'taty monitoringa effektivnosti i bezopasnosti primeneniya preparatov rekombinantnogo insulina cheloveka Biosulin R i Biosulin N u bol'nykh sakharnym diabetom 2 tipa v real'noy klinicheskoy praktike

Demidov N., Zakharova S., Zav'yalov A.

(Rus)

№ 10 (2015)

Ingibitory dipeptidilpeptidazy-4: novye vozmozhnosti effektivnogo glikemicheskogo kontrolya putem korrektsii narusheniy zhirovogo obmena u patsientov s sakharnym diabetom 2 tipa

Gusenbekova D., Ametov A., Butaeva S.

(Rus)

№ 5 (2015)

Klinicheskaya inertsiya v terapii sakharnogo diabeta 2 tipa

Antsiferov M.

(Rus)

№ 5 (2014)

TERAPIYa LIRAGLUTIDOM ZNAChITEL'NO ULUChShAET KONTROL' GLIKEMII I OKAZYVAET POLOZhITEL'NOE VLIYaNIE NA SERDEChNO-SOSUDISTUYu SISTEMU PATsIENTOV S SAKhARNYM DIABETOM 2 TIPA

Kudinov V., Nichitenko M., Chesnikova A.

(Rus)

№ 5 (2013)

PREIMUShchESTVA METFORMINA PROLONGIROVANNOGO DEYSTVIYa

Petunina N., Trukhina L., Sinitsyna E., Antsiferov M.

(Rus)

№ 11 (2012)

Osobennosti lecheniya narusheniy tolerantnosti k glyukoze u patsientov s abdominal'no-vistseral'nym tipom ozhireniya na rannikh etapakh ego razvitiya

Shilov A., Abdullaeva A.

(Rus)

№ 3 (2012)

PLACE OF DIBCOR® IN THE TREATMENT OF PATIENTS WITH TYPE 2 DIABETES MELLITUS AND METABOLIC SYNDROME

Vorokhobina N., Kuznetsova A., Vorohobina N., Kuznetsova A.

№ 16 (2011)

DIPEPTIDYL PEPTIDASE-4 INHIBITORS - NEW POTENTIALS FOR TREATMENT OF TYPE 2 DIABETES MELLITUS: EXPERIENCE OF USE OF GALVUS MET IN REAL-LIFE CLINICAL PRACTICE IN MOSCOW

Antsiferov M., Antciferov M.

№ 16 (2010)

INSULIN TREATMENT OF TYPE 2 DIABETES MELLITUS: A CHOICE AND AN INDIVIDUAL APPROACH

Biryukova Y., Biryukova E.

№ 5 (2010)

Thiazide diuretics and arterial hypertension: the history is going on

E Chazova I., Fomin V., Chazova I., Fomin V.

№ 3 (2010)

Sulfonylurea drugs and risk of cardiovascular complications - much ado about nothing?

Nedosugova L., Nedosugova L.

№ 3 (2009)

Do all we know about the thiazolidinediones, or what pioglitazone differs from rosiglitazone?

Mkrtumyan A., Mkrtumyan A.

Experience with the use of valsartan/sacubitril in patients with chronic heart failure in combination with type 2 diabetes mellitus and paroxysmal atrial fibrillation

Ignatenko A., Bagriy A., Prikolota A., Prikolota O., Mikhailichenko E., Golodnikov I., Bagriy O.

(Rus)

The use of sodium-glucose co-transporter type II (SGLT2) inhibitors in patients with chronic heart failure against the background of type 2 diabetes mellitus

Petrov V., Shatalova O., Klykova M., Stetsky N.

(Rus)

Том 29, № 4 (2022)

Efficacy and safety of ertugliflozin: results of the VERTIS CV sub-study in patients receiving a stable dose of insulin

Novikova M., Koteshkova O., Antsiferov M.

(Rus)

Том 28, № 12 (2021)

School of diabetes: new education module on insulin pump for patients with type 1 diabetes mellitus

Lisker A., Volkova A., Chernaya M., Mozgunova V., Durdyeva M.

(Rus)

Resistin levels and metabolic parameters in patients type 2 diabetes mellitus in combination with hypothyroidism

Verbovoy T., Lomonova T.

(Rus)

№ 11 (2018)

Alogliptin in the treatment of type 2 diabetes mellitus: an evidence base for the clinical use

Biryukova E.

(Rus)

№ 17 (2015)

Adipokiny i gormonal'no-metabolicheskie pokazateli u bol'nykh sakharnym diabetom 2 tipa i podagroy

Verbovoy A., Tsanava I., Verbovaya N.

(Rus)

№ 5 (2014)

UPRAVLENIE SAKhARNYM DIABETOM: ZNAChENIE STRUKTURIROVANNOGO SAMOKONTROLYa

Antsiferov M., Koteshkova O.

(Rus)

№ 16 (2013)

Osobennosti terapii perenesennogo insul'ta u bol'nykh sakharnym diabetom

Shavlovskaya O.

(Rus)

№ 16 (2013)

Rol' i mesto gipoglikemii v upravlenii sakharnym diabetom 2 tipa

Chernikova N., Antsiferov M.

(Rus)

№ 5 (2013)

O RATsIONAL'NOM VYBORE FARMAKOTERAPII PRI SAKhARNOM DIABETE 2 TIPA

Biryukova E.

(Rus)

№ 3 (2012)

DIABETES IN CHILDREN AND ADOLESCENTS: TO THE 90TH ANNIVERSARY OF THE INTRODUCTION OF INSULIN IN CLINICAL PRACTICE

Peterkova V., Peterkova V.

№ 3 (2011)

HOW TO ACHIEVE EFFECTIVE GLYCEMIC CONTROL AND REDUCE THE RISK OF VASCULAR COMPLICATIONS DUE TO USING SULFONYLUREA MEDICATIONS

Biryukova E., pl?midmagidsid Y.

№ 16 (2010)

CONTINUOUS SUBCUTANEOUS INSULIN INFUSION: EFFECTIVE METHOD FOR CONTROL OF TYPE 1 DIABETES MELLITUS

Antsiferov M., Koteshkova O., Kleimenova S., Antsiferov M., Koteshkova O., Kleymenova S.

№ 3 (2010)

Common bean (Phaseolus vulgaris L.)/

Samylina I., Sorokina A., Pyatigorskaya N., Samylina I., Sorokina A., Pyatigorskaya N.

№ 3 (2010)

Use of long-acting insulin analogues in type 2 diabetes mellitus treatment (according to the data of international and Russian registries)

Antsiferov M., Antsiferov M.

№ 17 (2009)

LEChENIE BOL'NYKh SAKhARNYM DIABETOM TIPA 2: PROBLEMY I PUTI IKh REShENIYa

Petunina N.

Том 31, № 8 (2024)

Optimization of approaches to the treatment of obesity in patients with type 2 diabetes mellitus

Kurnikova I., Chekalina M., Ualikhanova A.

(Rus)

Том 32, № 2 (2025)

Deintensification of insulin therapy in elderly patients with type 2 diabetes mellitus: impact on glycemic control and risk of hypoglycemia

Glinkina I., Oderiy A., Galkina A., Berdygylydzhova G., Fadeev V.

(Rus)

Том 29, № 11/12 (2022)

Efficacy and safety of fixed combination insulin glargine 100 u/ml and lixisenatide in patients with type 2 diabetes mellitus depending on age and baseline HbA1C in the SOLO study

Antsiferov M., Demidov N., Safronova T., Mishra O.

(Rus)

Том 29, № 4 (2022)

The role of menopausal hormone therapy in the prevention of type 2 diabetes melltus in postmenopausal women

Apetov S., Apetova V.

(Rus)

Том 28, № 12 (2021)

P-cell dysfunction in type 2 diabetes mellitus: the possibilities of modern antihyperglycemic therapy

Chernikova N.

(Rus)

Том 28, № 3 (2021)

The choice of antianginal therapy for polymordib patients with coronary artery disease and type 2 diabetes mellitus: the benefits of trimetazidine

Kochetkov A., Pereverzev A., Ostroumova O., Gusenbekova D., Romanovsky R., Shatalova N.

(Rus)

Effect of Subetta on glycemic control in patients with type 2 diabetes mellitus: results of a multicenter, double-blind, placebo-controlled, randomized clinical study

Mkrtumyan A., Vorobyev S., Volkova A., Vorokhobina N.

(Rus)

Том 27, № 4 (2020)

Is it possible to stop the diabetes epidemic?

Verbovoy A., Dolgikh Y., Verbovaya N.

(Rus)

Том 26, № 14 (2019)

Hypoglycemic drugs and drug-induced heart failure

Ostroumova O., Goloborodova I.

(Rus)

The state of carbohydrate metabolism and the development of cerebrovascular diseases in patients with type 2 diabetes mellitus

Antonova K., Tanashyan M., Maksimova M., Shakhparonova N., Romantsova T.

(Rus)

№ 16 (2017)

Disturbances of the autonomic innervation of the cardiovascular system and hemostasis: their role in the change of microcirculation in patients with type 2 diabetes mellitus

Tsvetkova I., Kaukova A., Belyakova N., Vasyutkova O., Konovalova O., Lareva A.

(Rus)

№ 5 (2017)

EFFICIENCY AND SAFETY OF USE OF CANAGLIFLOZIN IN THE OUTPATIENT PRACTICE

Demidov N., Antsiferov M., Dorofeeva L.

(Rus)

№ 5 (2016)

APPLICATION OF SAXAGLIPTIN AND ITS COMBINATION WITH METFORMIN IN THE THERAPY OF TYPE 2 DIABETES MELLITUS IN ELDERLY PATIENTS

Antsiferov M.

(Rus)

№ 17 (2015)

Gipoglikemiya i kachestvo zhizni bol'nykh sakharnym diabetom 2 tipa

Antsiferov M., Nikitina T., Rodionova A., Kurbatova K., Ionova T.

(Rus)

№ 16 (2014)

Fiksirovannaya kombinatsiya saksagliptina i metformina modifitsirovannogo vysvobozhdeniya - novyy shag v uluchshenii priverzhennosti k lecheniyu sakharnogo diabeta 2 tipa

Biryukova E.

(Rus)

№ 16 (2013)

Upravlenie lipotoksichnost'yu v debyute sakharnogo diabeta 2 tipa

Ametov A., Tertychnaya E.

(Rus)

№ 5 (2013)

SAKhARNYY DIABET 2 TIPA I NEALKOGOL'NAYa ZhIROVAYa BOLEZN' PEChENI: PRAKTIChESKIE REKOMENDATsII DLYa ENDOKRINOLOGOV

Ametov A.

(Rus)

№ 20 (2012)

Vybor gliptinov v raznykh klinicheskikh situatsiyakh - kommentarii k portretam patsientov

Ruyatkina L., Sorokin M.

(Rus)

№ 10 (2012)

Rol' terapevticheskogo obucheniya patsientov na pompovoy insulinoterapii

Ametov A., Valitov B., Chernikova N., Antsiferov M.

(Rus)

№ 3 (2012)

GLUCAGON-LIKE PEPTIDE-1: FROM PHYSIOLOGY TO EFFECTIVE MANAGEMENT OF TYPE 2 DIABETES MELLITUS

Antsiferov M., Antsiferov M.

№ 3 (2011)

RESULTS OF OBSERVATIONAL PROGRAM ON USE OF INSULIN GLARGINE (LANTUS®) IN COMBINATION WITH ORAL HYPOGLYCEMIC AGENTS FOR THE TREATMENT OF TYPE 2 DIABETES MELLITUS IN ROUTINE CLINICAL PRACTICE

Glinkina I., Romantsova T., Glinkina I., Romantsova T.

№ 3 (2011)

TYPE 2 DIABETES MELLITUS: POTENTIALS FOR ACHIEVEMENT OF OPTIMAL CONTROL WITHOUT SIDE EFFECTS

Antsiferov M., Antsiferov M.

№ 17 (2009)

SOVREMENNYE PODKhODY K LEChENIYu SAKhARNOGO DIABETA TIPA 2 U MUZhChIN

Tishova Y., Kalinichenko S.

№ 3 (2009)

Metformin - pathogenetic drug of first-line in the treatment of type 2 diabetes

Zilov A., Zilov A.

Том 32, № 2 (2025)

Dynamics of the structure of non-insulin antihyperglycemic drug use in the treatment of type 2 diabetes mellitus (data from the Moscow segment Federal Diabetes Registry)

Demidov N.

(Rus)

News of medicine

Kudinova S.

(Rus)

Combination of two hypoglycemic drugs for type 2 diabetes mellitus

Morgunova T., Fadeyev V.

(Rus)